Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Genomic Medicine Center of Excellence, |
RCV003990911 | SCV004807992 | uncertain significance | Basal ganglia calcification, idiopathic, 7, autosomal recessive | 2024-03-29 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV004654380 | SCV005146155 | uncertain significance | not specified | 2024-06-22 | criteria provided, single submitter | clinical testing | The c.319G>A (p.G107R) alteration is located in exon 2 (coding exon 1) of the KIAA1161 gene. This alteration results from a G to A substitution at nucleotide position 319, causing the glycine (G) at amino acid position 107 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |